This doubles the weight loss effects seen in the initial liraglutide trials (2014) , suggesting that dosing regimens may be key to effective treatment (and differ from those used in T2D)
Mroz, P
Adding to what we know about GLP-1 medications and colorectal cancer risk, Cuomo is the lead author of a new study recently published in the journal Cancer Investigation, which found that GLP-1 medications may help lower mortality risk for people who have colon cancer, a type of colorectal cancer
It is also about blood pressure, inflammation, kidney protection, fatty liver disease, cardiovascular risk, sleep, mobility, and overall metabolic health
At the time, the finding seemed interesting but not especially groundbreaking
The trillions of bacteria living in the digestive tract help produce compounds that influence hormone signalingincluding GLP-1